1. APIs
  2. Estradiol
  3. US FDA-Approved Products
  4. Vivelle, #020323

Vivelle, #020323

Product Category

US FDA-Approved Medicine

Formulation

ESTRADIOL: 0.0375 mg/day, 0.075 mg/day, 0.025 mg/day Film, extended release; transdermal Discontinued ESTRADIOL: 0.05 mg/day, 0.1 mg/day Film, extended release; transdermal Prescription

Delivery Method

Film, Extended Release; Transdermal

Status

Discontinued

ANDA #

020323

Approval Date

19941028

Manufacturers

Novartis

References

  1. Drugs@FDA Online Database (View all citations for this reference)